ES2642712T3 - Péptidos de foenixina - Google Patents

Péptidos de foenixina Download PDF

Info

Publication number
ES2642712T3
ES2642712T3 ES12789015.0T ES12789015T ES2642712T3 ES 2642712 T3 ES2642712 T3 ES 2642712T3 ES 12789015 T ES12789015 T ES 12789015T ES 2642712 T3 ES2642712 T3 ES 2642712T3
Authority
ES
Spain
Prior art keywords
foenixin
peptides
image
image2
image2 image3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12789015.0T
Other languages
English (en)
Inventor
Rong-Ming Lyu
Jaw-Kang Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenix Pharmaceuticals Inc
Original Assignee
Phoenix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Pharmaceuticals Inc filed Critical Phoenix Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2642712T3 publication Critical patent/ES2642712T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Tires In General (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
    imagen2
ES12789015.0T 2011-05-26 2012-05-25 Péptidos de foenixina Active ES2642712T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161519747P 2011-05-26 2011-05-26
US201161519747P 2011-05-26
US201161519746P 2011-05-28 2011-05-28
US201161519746P 2011-05-28
PCT/US2012/039743 WO2012162679A1 (en) 2011-05-26 2012-05-25 Phoenixin peptides

Publications (1)

Publication Number Publication Date
ES2642712T3 true ES2642712T3 (es) 2017-11-17

Family

ID=47217800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12789015.0T Active ES2642712T3 (es) 2011-05-26 2012-05-25 Péptidos de foenixina

Country Status (7)

Country Link
US (4) US9018350B2 (es)
EP (1) EP2714717B1 (es)
JP (1) JP2014518881A (es)
CN (1) CN103703016A (es)
CA (1) CA2874130C (es)
ES (1) ES2642712T3 (es)
WO (1) WO2012162679A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018350B2 (en) 2011-05-26 2015-04-28 Phoenix Pharmaceuticals, Inc. Phoenixin peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441936A (en) 1993-12-07 1995-08-15 Houghten Pharmaceuticals, Inc. Antiviral peptides
AU8921598A (en) * 1997-08-29 1999-03-16 Human Genome Sciences, Inc. 29 human secreted proteins
EA200601749A1 (ru) * 2004-03-23 2007-06-29 Зе Боард Оф Трастиз Оф Зе Лилэнд Стэнфорд Джуниор Юниверсити Коспептин, космедин и варианты их применения
EP1628136A1 (en) 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
EP2403518A4 (en) 2009-03-06 2013-01-23 Angstrom Pharmaceuticals Inc Compositions and methods for modulating cell migration
US9018350B2 (en) 2011-05-26 2015-04-28 Phoenix Pharmaceuticals, Inc. Phoenixin peptides

Also Published As

Publication number Publication date
EP2714717A1 (en) 2014-04-09
US20210061893A1 (en) 2021-03-04
CA2874130C (en) 2021-06-22
JP2014518881A (ja) 2014-08-07
US20140163202A1 (en) 2014-06-12
US20170145083A1 (en) 2017-05-25
EP2714717A4 (en) 2015-03-25
US9534045B2 (en) 2017-01-03
US20150322141A1 (en) 2015-11-12
US10836812B2 (en) 2020-11-17
CA2874130A1 (en) 2012-11-29
WO2012162679A1 (en) 2012-11-29
US9018350B2 (en) 2015-04-28
EP2714717B1 (en) 2017-07-05
CN103703016A (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
ES2644844T3 (es) Mecanismo de soporte
ES2644822T3 (es) Carrete de cordón retráctil
ES2642212T3 (es) Cierre de cremallera
ES2471951T3 (es) Procedimiento y dispositivo para el estampado en caliente
ES2644809T3 (es) Sistema de generación de gas inerte a bordo
DK2612297T3 (da) Tredimensionelt billedsystem
ES2448766T9 (es) Profármacos de dolutegravir
DK3410725T3 (da) Referencebilledsignalering
BR112013022911A2 (pt) gerenciamento de armazenador de imagem decodificada
JP2013525942A5 (es)
JP2012255926A5 (es)
BR112014004902A2 (pt) peptídeos
JP2011170856A5 (es)
ES2642399T3 (es) Material cosmético emulsionado
BR112013012755A2 (pt) projetor
ES2643814T3 (es) Carretilla elevadora equipada con medios de estabilización
ES2644443T3 (es) Producción biotecnológica de condroitina
JP2012204203A5 (es)
DK2764405T3 (da) Kamera
BR112014001383A2 (pt) aparelho de formação de imagem
BR112013023301A2 (pt) projetor
ES2567082T9 (es) Transformador de turbina eólica
BR112013018812A2 (pt) projetor
BR112013020369A8 (pt) peptídeos modificados hidrofóbicos para diagnóstico específico do fígado.
DK2734834T3 (da) Røntgenbilleddannelse